Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Blood and Lymphatic Cancer : Targets and Therapy|August 16, 2019
<i>IDH1</i>-mutated relapsed or refractory AML: current challenges and future prospectsJuan Eduardo Megías-Vericat, Octavio Ballesta-López, Eva Barragán, et al.
Blood Reviews|March 10, 2020
Tyrosine kinase inhibitors for acute myeloid leukemia: A step toward disease control?Juan Eduardo Megías-Vericat, Octavio Ballesta-López, Eva Barragán, et al.
Expert Opinion on Emerging Drugs|January 25, 2022
Emerging FLT3 inhibitors for the treatment of acute myeloid leukemiaAntonio Solana-Altabella, Octavio Ballesta-López, Juan Eduardo Megías-Vericat, et al.
Future Oncology (London, England)|September 25, 2020
Gilteritinib use in the treatment of relapsed or refractory acute myeloid leukemia with a <i>FLT3</i> mutationOctavio Ballesta-López, Antonio Solana-Altabella, Juan Eduardo Megías-Vericat, et al.
Expert Review of Clinical Pharmacology|January 28, 2023
Drug-drug interactions associated with FLT3 inhibitors for acute myeloblastic leukemia: current landscapeAntonio Solana-Altabella, Juan Eduardo Megías-Vericat, Octavio Ballesta-López, et al.
Annals of Hematology|July 20, 2020
Drug-drug interactions of newly approved small molecule inhibitors for acute myeloid leukemiaJuan Eduardo Megías-Vericat, Antonio Solana-Altabella, Octavio Ballesta-López, et al.
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|April 5, 2022
Proactive therapeutic drug monitoring and pharmacogenetic analysis in inflammatory bowel disease: A systematic reviewOctavio Ballesta-López, María Centelles-Oria, María Remedios Marqués-Miñana, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 14, 2020
Adherence and adverse events of intraperitoneal chemotherapy in optimally debulked ovarian cancer patients: Real-life studyOctavio Ballesta-López, Asunción Albert-Marí, Carmela Borrell-García, et al.
European Journal of Hospital Pharmacy : Science and Practice|August 22, 2024
Toxic-metabolic encephalopathy induced by metronidazole and disulfiram: classics never dieMaria Choví-Trull, Octavio Ballesta-López, Gema Amparo Navarro Buendia, et al.
International Journal of Molecular Sciences|February 26, 2025
Pharmacogenetics in Response to Biological Agents in Inflammatory Bowel Disease: A Systematic ReviewOctavio Ballesta-López, Mayte Gil-Candel, María Centelles-Oria, et al.
Pageof 2